IDbyDNA Participates in NIH National COVID-19 Genomics Consortium

May 7, 2020

The CDC is leading the national SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance initiative (SPHERES) to coordinate SARS-CoV-2 sequencing across the U.S. Utah’s own IDbyDNA will be participating in the effort along with clinical and public health laboratories, academic institutions, and other private sector companies. The SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.

In addition to IDbyDNA, corporate participants include Abbott Diagnostics, BioMérieux, Color, Ginkgo Bioworks, Illumina, In-Q-Tel, LabCorp, One Codex, Oxford Nanopore Technologies, Pacific Biosciences, Qiagen, Quest Diagnostics, and Verily Life Sciences.